C. Leister

发表

Population Pharmacokinetics of CCI‐779: Correlations to Safety and Pharmacogenomic Responses in Patients with Advanced Renal Cancer

A. Dorner, J. Boni, M. Burczynski, 2005, Clinical pharmacology and therapeutics.

Ascending single-dose study of the safety profile, tolerability, and pharmacokinetics of bosutinib coadministered with ketoconazole to healthy adult subjects.

D. Sonnichsen, R. Abbas, S. Chalon, 2012, Clinical therapeutics.

A randomized, crossover, placebo‐ and moxifloxacin‐controlled study to evaluate the effects of bosutinib (SKI‐606), a dual Src/Abl tyrosine kinase inhibitor, on cardiac repolarization in healthy adult subjects

B. Hug, D. Sonnichsen, R. Abbas, 2012, International journal of cancer.

A Single-Dose, Crossover, Placebo- and Moxifloxacin-Controlled Study to Assess the Effects of Neratinib (HKI-272) on Cardiac Repolarization in Healthy Adult Subjects

B. Hug, D. Sonnichsen, R. Abbas, 2010, Clinical Cancer Research.

Effect of Ketoconazole on the Pharmacokinetics of Oral Bosutinib in Healthy Subjects

B. Hug, D. Sonnichsen, R. Abbas, 2011, Journal of clinical pharmacology.

Pharmacokinetics and safety of lefamulin after single intravenous dose administration in subjects with impaired renal function and those requiring hemodialysis

T. Marbury, S. Gelone, J. Crandon, 2021, Pharmacotherapy.

A double-blind, randomized, multiple-dose, parallel-group study to characterize the occurrence of diarrhea following two different dosing regimens of neratinib, an irreversible pan-ErbB receptor tyrosine kinase inhibitor

B. Hug, D. Sonnichsen, R. Abbas, 2012, Cancer Chemotherapy and Pharmacology.

Pharmacokinetics of oral neratinib during co-administration of ketoconazole in healthy subjects.

B. Hug, D. Sonnichsen, R. Abbas, 2011, British journal of clinical pharmacology.

Intravenous temsirolimus in cancer patients: clinical pharmacology and dosing considerations.

B. Hug, J. Boni, D. Sonnichsen, 2009, Seminars in oncology.

Differential effects of ketoconazole on exposure to temsirolimus following intravenous infusion of temsirolimus

B. Hug, J. Boni, C. Leister, 2008, British Journal of Cancer.

A single-dose placebo- and moxifloxacin-controlled study of the effects of temsirolimus on cardiac repolarization in healthy adults

B. Hug, J. Boni, D. Sonnichsen, 2012, Cancer Chemotherapy and Pharmacology.

A Clinical Study to Examine the Potential Effect of Lansoprazole on the Pharmacokinetics of Bosutinib when Administered Concomitantly to Healthy Subjects

D. Sonnichsen, R. Abbas, C. Leister, 2013, Clinical Drug Investigation.

Evaluation of the pharmacokinetics and safety of bosutinib in patients with chronic hepatic impairment and matched healthy subjects

D. Sonnichsen, R. Abbas, S. Chalon, 2012, Cancer Chemotherapy and Pharmacology.

Pharmacokinetic Profile of Temsirolimus With Concomitant Administration of Cytochrome P450‐Inducing Medications 1

B. Hug, J. Boni, L. Moore, 2007, Journal of clinical pharmacology.

A phase I ascending single-dose study of the safety, tolerability, and pharmacokinetics of bosutinib (SKI-606) in healthy adult subjects

B. Hug, D. Sonnichsen, R. Abbas, 2011, Cancer Chemotherapy and Pharmacology.

PHARMACOKINETICS OF ONCE-DAILY VENLAFAXINE EXTENDED RELEASE IN HEALTHY VOLUNTEERS

S. Troy, R. Fruncillo, Patrick Martin, 1997 .

Safety and pharmacokinetics of escalated doses of weekly intravenous infusion of CCI-779, a novel mTOR inhibitor, in patients with cancer.

E. Raymond, J. Armand, S. Faivre, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparison of the effects of zaleplon, zolpidem, and triazolam on memory, learning, and psychomotor performance.

I. Lucki, P. Furlan, S. Troy, 2000, Journal of clinical psychopharmacology.

Interrupted Time Series Analysis in Clinical Research

L. Matowe, J. Korth-Bradley, C. Crivera, 2003, The Annals of pharmacotherapy.

Pharmacokinetics and safety of lefamulin after single intravenous dose administration in subjects with impaired‐hepatic function

T. Marbury, S. Gelone, J. Crandon, 2021, Pharmacotherapy.

Effect of zaleplon on digoxin pharmacokinetics and pharmacodynamics.

J. Frías, P. Guerra, C. Leister, 2000, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Absence of an interaction between ibuprofen and zaleplon.

A. Carcas, S. Troy, P. Zapater, 2000, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Disposition of desipramine, a sensitive cytochrome P450 2D6 substrate, when coadministered with intravenous temsirolimus

B. Hug, J. Boni, R. Abbas, 2009, Cancer Chemotherapy and Pharmacology.

Abstract PR06: Phase 1b dose-escalation study of trametinib (MEKi) plus palbociclib (CDK4/6i) in patients with advanced solid tumors

R. Sullivan, K. Flaherty, J. Sosman, 2015 .

A Phase 1, Randomized Study Evaluating the Safety Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Single Ascending Doses of Epinephrine Prodrug 109 Sublingual Film (AQST-109) in Healthy Male Volunteers

M. Lepore, J. Oppenheimer, R. Kainthan, 2022, Journal of Allergy and Clinical Immunology.

Population Pharmacokinetics of CCI‐779: Correlations to Safety and Pharmacogenomic Responses in Patients with Advanced Renal Cancer

A. Dorner, J. Boni, M. Burczynski, 2005, Clinical pharmacology and therapeutics.